Press Releases
- Pew statement on House hearing regarding FDA drug safety reforms 03/10/2010
- Medical students, Pew Prescription Project find improvement in medical school pharmaceutical conflict-of-interest policies, but many lag 06/16/2009
- The Prescription Project applauds legislation requiring disclosure of physician-industry relationships 01/22/2009
- The Prescription Project criticizes new PhRMA DTCA guidelines New guidelines fail to protect consumers from drug risks 12/10/2008
- The Prescription Project petitions FDA to order pharmaceutical and medical device companies to remove illegal internet ads Abbott, Medtronic and Stryker YouTube videos fail to include required product warning statements 12/03/2008
- Prescription Project Welcomes U.S. Appeals Court Ruling in “Data-Mining” Case 11/18/2008
- Prescription Project, Massachusetts Prescription Reform Coalition on Governor to Sign Qualtiy and Cost Control Bill 08/08/2008
- Senate, House introduce academic detailing bill to provide unbiased drug information to doctors 07/31/2008
- Prescription Project statement on PhRMA's revised code on marketing The following is the statement of Robert Restuccia, Executive Director of The Prescription Project, a national campaign to end conflicts of interest in medicine due to pharmaceutical marketing. 07/10/2008
- Majority of Americans support legislative action to disclose pharmaceutical company gifts to physicians New survey shows Americans are eager to understand financial ties between physicians and pharmaceutical industry; array of gifts largely considered unacceptable 06/18/2008
- Massachusetts coalition to control drug costs launches at State House 01/17/2008
- Prescription Project lauds DC City Council for reining in pharmaceutical marketing with Safe Rx Act First-in-nation law will hold drug reps to truth-in-advertising, give doctors alternative unbiased sources of information on prescription drugs 01/11/2008
- New survey highlights drug samples' role as marketing tool Prescription Project urges physicians and academic medical centers to ban or regulate samples, make prescribing decisions based on unbiased evidence 01/03/2008
- Prescription Project, National Physicians Alliance join forces to stem negative influence of marketing on health care The Prescription Project and the National Physicians Alliance (NPA) today announced a partnership to engage physicians in a nationwide campaign to eliminate the harmful influence of pharmaceutical marketing on the cost, quality, and safety of health care. 10/19/2007
- Prescription Project reports that industry spends $50 million in marketing cough and cold meds for children each year despite risks Report says lack of results, risks for children under six does not deter drug company marketing of these products as “safe and effective” 10/18/2007
- Prescription Project Calls BMC-BUSM Conflict-of-Interest Guidelines Among Top in Nation The decision by Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) to adopt strict guidelines to prevent conflicts of interest between doctors and pharmaceutical companies puts Massachusetts in a position to lead the nation to fix this troubling issue 09/06/2007
- Prescription Project calls prescriber data lawsuits flawed Releases legal analysis that shows strong legal case in support of Maine and Vermont laws 08/31/2007
- Coalition urges American Medical Association to halt sale of physician data to pharmaceutical marketing firms The Prescription Project, National Physicians Alliance and American Medical Student Association today urged the American Medical Association to stop selling its comprehensive physician database, known as the Physician Masterfile, to companies that use it to create profiles for pharmaceutical marketing purposes. 06/25/2007
- States move forward with prescription drug reform as NH appeals US District Court ruling Even as New Hampshire Attorney General Kelly Ayotte announced her decision to appeal the New Hampshire Federal District Court ruling that struck down her state’s ban on some “data mining” practices last week, Maine and Vermont made strong bicameral advances on prescription drug reform bills. 05/11/2007
- Ties between drug companies and physicians still too strong A new study published today in the New England Journal of Medicine on the extent of doctor and pharmaceutical company relationships, highlights the need for profession-wide and public policy reforms promoted by The Prescription Project. 04/26/2007
- National-State Alliance Aims to Reduce Medical Conflicts-of-Interest through Improving Patient-Care, Lowering Drug Costs The Prescription Project today launched a new initiative with the Minnesota Senior Federation (MnSF) to assist consumers, doctors and health plans in combating the influence of drug industry marketing in order to improve patient care and lower prescription drugs costs. 04/25/2007
- New Campaign Champions Changes In Medical Prescribing To End Conflicts Of Interest The Prescription Project today called on academic medical centers, professional medical societies and public and private payers to end conflicts of interest resulting from the $12 billion spent annually on pharmaceutical marketing. 02/12/2007
Get the latest news and updates from The Prescription Project
Congress hears from FDA on drug safety two years after heparin scare 03/05/2010
"Marketplace" follows academic detailers in Pennsylvania 02/24/2010
Sunshine rules in White House health care bill 02/22/2010
JAMA: RxP and consumers, industry weigh online ads at FDA hearing 01/26/2010
Miami Herald: RxP says voluntary disclosures inconsistent, don't capture CME 01/25/2010
